Suchergebnisse - (Standardsuche:issn:"1568-0096" OR issn:"1873-5576")

PubPharm (85)

1

An Overview of CDK Enzyme Inhibitors in Cancer Therapy

enthalten in: Current cancer drug targets | 2023

von Mounika, P. | Gurupadayya, B. | Kumar, H. | +1

2

Inhibitors and Activators of the p38 Mitogen-Activated MAP Kinase (MAPK) Family as Drugs to Treat Cancer and Inflammation

enthalten in: Current cancer drug targets | 2022

von Denny, W.

3

Targeting IDH Mutations in AML : Wielding the Double-edged Sword of Differentiation

enthalten in: Current cancer drug targets | 2020

von Becker, J. | Fathi, A.

4

Advances in In-Silico based Predictive In-Vivo Profiling of Novel Potent β-Glucuronidase Inhibitors

enthalten in: Current cancer drug targets | 2019

von Yousuf, M.

5

c-Myc Inhibitor 10074-G5 Induces Murine and Human Hematopoietic Stem and Progenitor Cell Expansion and HDR Modulator Rad51 Expression

enthalten in: Current cancer drug targets | 2019

von Aksoz, M. | Albayrak, E. | Aslan, G. | +10

6

Aldose Reductase Inhibitor, Fidarestat Prevents High-fat Diet-induced Intestinal Polyps in ApcMin/+ Mice

enthalten in: Current cancer drug targets | 2018

von Saxena, A. | Tammali, R. | Ramana, K. | +1

7

UDP-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase- 6 (pp-GalNAc-T6) : Role in Cancer and Prospects as a Drug Target

enthalten in: Current cancer drug targets | 2017

von Banford, S. | Timson, D.

8

G9a - An Appealing Antineoplastic Target

enthalten in: Current cancer drug targets | 2017

von Chen, W. | Sun, H. | Li, D. | +3

9

Influence of Aldo-keto Reductase 1C3 in Prostate Cancer - A Mini Review

enthalten in: Current cancer drug targets | 2017

von Karunasinghe, N. | Masters, J. | Flanagan, J. | +1

10

Indoleamine 2,3-dioxygenase (IDO) : Biology and Target in Cancer Immunotherapies

enthalten in: Current cancer drug targets | 2016

von Selvan, S. | Dowling, J. | Kelly, W. | +1

1
2
3
4
5
6
7
8
9
Nächster »
[9]